Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3423419 | Trends in Parasitology | 2008 | 4 Pages |
Abstract
It has been often observed that the chemotherapeutic armamentarium against an important disease such as schistosomiasis consists of just one drug, praziquantel. Thus, development of drug resistance is an impending danger, with serious implications for the health protection of many millions of people. This rational and legitimate concern might now begin to be relieved by the recent proposal of a new class of compounds that could represent a novel source of drugs against schistosomiasis.
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
Donato Cioli, Cristiana Valle, Francesco Angelucci, Adriana E. Miele,